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Abstract
Background: Acinetobacter baumannii is an emerging bacterial pathogen that causes a broad array of infections, particularly
in hospitalized patients. Many studies have focused on the epidemiology and antibiotic resistance of A. baumannii, but little
is currently known with respect to its virulence potential.
Methodology/Principal Findings: The aim of this work was to analyze a number of virulence-related traits of four A.
baumannii strains of different origin and clinical impact for which complete genome sequences were available, in order to
tentatively identify novel determinants of A. baumannii pathogenicity. Clinical strains showed comparable virulence in the
Galleria mellonella model of infection, irrespective of their status as outbreak or sporadic strains, whereas a non-human
isolate was avirulent. A combined approach of genomic and phenotypic analyses led to the identification of several
virulence factors, including exoproducts with hemolytic, phospholipase, protease and iron-chelating activities, as well as a
number of multifactorial phenotypes, such as biofilm formation, surface motility and stress resistance, which were
differentially expressed and could play a role in A. baumannii pathogenicity.
Conclusion/Significance: This work provides evidence of the multifactorial nature of A. baumannii virulence. While A.
baumannii clinical isolates could represent a selected population of strains adapted to infect the human host,
subpopulations of highly genotypically and phenotypically diverse A. baumannii strains may exist outside the hospital
environment, whose relevance and distribution deserve further investigation.
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Introduction
Acinetobacter baumannii is an emerging human pathogen which
causes a broad array of infections (e.g. pneumonia, urinary tract,
bloodstream and skin infections) that account for about 10% of all
nosocomial infections [1,2,3]. Since the 1980s, three main
epidemic A. baumannii lineages, hereafter referred to as clonal
complexes I, II and III (CC1, CC2 and CC3, respectively) have
emerged and spread internationally throughout many geograph-
ical areas [4]. Both multi-locus sequence typing and comparative
genomics analysis revealed that isolates belonging to the same CC
are highly homogenous, suggestive of a recent clonal expansion
[4,5]. These three lineages are characterized by multidrug
resistance (MDR), a phenotype that has been expanding
alarmingly over the years, with frequent reports of A. baumannii
strains resistant to almost all clinically relevant antibiotics [6,7].
While the epidemiology and antibiotic resistance of A. baumannii
strains has been extensively studied, limited information is so far
available concerning the virulence and pathogenicity traits of this
bacterium. Cohort and case-control clinical studies have shown
that A. baumannii infections can be severe, and clinical observations
have posed the question of the existence of a strain-dependent
pathogenicity [8]. However, the molecular and genetic basis of A.
baumannii virulence remains poorly understood, and only a few
determinants have been demonstrated to be important for A.
baumannii virulence in vivo. One of these is OmpA, an outer
membrane protein which adheres to and is taken up by epithelial
cells, where it can induce apoptosis [9]. OmpA is also implicated
in resistance to complement and biofilm formation [10,11].
Recently, other proteins have also been proposed to contribute
to A. baumannii virulence. A phospholipase D has been demon-
strated to be important for resistance to human serum, epithelial
cell invasion and pathogenesis in a murine model of pneumonia
[12], while a phospholipase C has been shown to enhance toxicity
to epithelial cells [13]. Moreover, a transposon mutant in a gene
for penicillin binding protein 7/8 showed reduced virulence in rat
pneumonia and soft-tissue models, as well as reduced serum
resistance [14].
Several other factors have been investigated as potential
determinants of A. baumannii pathogenicity, but their role has not
yet been definitively ascertained. Capsular polysaccharide has
been implicated in serum resistance since mutants in its
biosynthetic pathway fail to survive in human serum [15]. The
extracellular polysaccharide poly-b-(1–6)-N-acetyl glucosamine
PLoS ONE | www.plosone.org 1 August 2011 | Volume 6 | Issue 8 | e22674(PNAG), synthesized by the pgaABCD locus, and the Csu pili play a
role in biofilm formation [16,17], while a homologue of the
staphylococcal biofilm-associated protein (Bap) is required for the
development of mature biofilm structures [18]. Quorum sensing
has been also shown to contribute to biofilm formation [19], but
did not affect virulence in the Galleria mellonella insect model of
infection [20]. In addition, some but not all A. baumannii isolates
show gelatinase activity and cause mannose-resistance hemagglu-
tination [21]. Moreover, different A. baumannii isolates display
diverse resistance to desiccation [22], a feature that can influence
persistence in the hospital environment.
Finally, bacterial pathogenicity is intimately linked to the ability
to use specific iron acquisition strategies, which are essential for
pathogen survival and growth in the low-iron environment of the
human host [23]. In addition to the well-characterized siderophore
acinetobactin [24], genome investigations have recently shown
that A. baumannii has the potential to express several iron-
acquisition systems, including two other siderophores, one shared
by all A. baumannii strains sequenced to date, with the exception of
SDF, while the other is so far unique to ATCC 17978, two heme-
uptake systems and a ferrous iron acquisition [25,26].
The aim of the present work was to identify specific virulence
determinant(s) that could contribute to the success of A. baumannii as
a human pathogen, and to investigate whether the occurrence of
such virulence determinants in representative strains of the two
main clonal lineages, CC1 and CC2, could explain the increased
ability of these lineages to cause infection and persist in the hospital
setting. In this context, four A. baumannii strains of different origin
(three clinical isolates and one isolate from a human body louse),
belonging to diverse clonal complexes, whose genomes were
completely sequenced and annotated, were comparatively analyzed
by a combination of genome- and phenotype-based strategies. This
led to the identification of a number of virulence factors that could
contribute to the pathogenic potential of A. baumannii.
Materials and Methods
Ethics Statement
Serum was obtained from five healthy volunteers who gave their
written informed consent to the study, which was approved by the
Review Board of the Department of Biology of the University
Roma Tre.
Bacterial strains and culture conditions
Bacterial strains used in this study were A. baumannii AYE,
ACICU, ATCC 17978 and SDF, and Pseudomonas aeruginosa PAO1
(ATCC 15692). AYE strain is an epidemic multidrug-resistant
clinical isolate responsible for a nationwide outbreak in France in
2001 [27]; ACICU is an epidemic multidrug-resistant clinical
isolate responsible for an outbreak in Rome (Italy) in 2005 [28];
ATCC 17978 was isolated in 1951 from a 4-month-old infant with
fatal meningitis, and differs from AYE and ACICU in being
susceptible to most common antibiotics [29]; SDF is a fully
antibiotic-susceptible strain isolated from a human body louse
[27]. Since A. baumannii is rarely found on the human skin, it has
been proposed that the association of SDF with a non-human host
is the result of the louse’s ingestion of contaminated blood from an
individual with undiagnosed A. baumannii bacteremia [30]. Strains
AYE and ACICU are phylogenetically grouped inside CC1 and
CC2, respectively, whereas ATCC 17978 and SDF represent two
discrete and less common lineages within the A. baumannii
population [4]. No isolates belonging to the CC3 have been
completely sequenced to date, and thus representatives of this
clonal lineage were not included in this study.
Bacteria were cultured in Luria-Bertani broth (LB), minimal
broth M9 with succinate as carbon source [31], Chelex 100-
treated trypticase soy broth dialysate (TSBD) [32] and casamino
acid medium supplemented with 0.4 mM MgCl2 (CAA) [33].
When required, media were supplemented with either 50 mM
2,29-dipyridyl or 50 mM FeCl3 to generate low- and high-iron
growth conditions, respectively.
G. mellonella killing assay
The G. mellonella virulence assay was performed as described
previously [34], with minor modifications. G. mellonella caterpillars
in the final instar larval stage (average weight 500660 mg) were
injected with 10 ml of serial ten-fold dilutions in saline solution of
A. baumannii cells grown for 14 h at 37uC in TSBD. Bacterial
colony counts on LB agar plates were used to estimate the number
of viable cells in each inoculum. At least 20 larvae were inoculated
per experiment, with a total of at least three dependent and three
independent experiments per strain. Ten larvae per experiment
were injected with 10 ml of sterile saline solution as a negative
control. Larvae were incubated at 37uC in Petri dishes (five larvae
per dish) and monitored for a three-day time period. Larvae were
considered dead when they did not respond to gentle prodding
[34]. When required, bacterial cells were heat-killed by incubation
at 80uC for 60 min. Lethal dose 50% (LD50) values were
calculated using GraphPad Prism and the following equation:
Y=A+(1 - A)/[1+exp (B - G6lnX)], where X is the number of
viable bacterial cells injected, Y the fraction of larvae killed by the
bacterial solution, A is the fraction of larvae killed by the control
solution, and B and G are curve-fitting constants automatically
calculated by GraphPad Prism [34]. LD50 was calculated as the
value of X that corresponds to Y=0.5.
Growth assays
Cells from overnight cultures in a given medium were
normalized to an OD600 of 0.01 in the same medium and grown
at 4, 25, 30, 37, 42, 45 or 50uC for 24 h with vigorous aeration
(250 rpm). The culture cell density was determined every hour by
measuring the OD600. Maximum specific growth rates (mmax) were
determined by fitting growth data to a logistic growth curve using
GraphPad Prism and the following equation: Y=YM6Y0/
((YM2Y0)6e
2xk+Y0), where Y0 and YM represent OD600 values
at time points 0 and M, respectively, k is a constant calculated
automatically by the program and x represents the time of growth
(in hours). Each mmax was calculated as the derivative of the
equation for the time point of maximum growth. The coefficient of
determination (R
2) was used to verify the goodness of fit of the data
to the equation.
Resistance to iron starvation and production of
iron-chelating compounds
Resistance to iron starvation was assessed on TSBD agar plates
containing a linear gradient of the iron chelator 2,29-dipyridyl,
ranging from 0 to 500 mM, generated according to the agar
gradient-plate technique [35]. A. baumannii strains were grown in
TSBD at 37uC for 14 h and then inoculated with a sterile loop
handle onto the plates, starting from the side with the highest
concentration of the iron chelator. Plates were incubated at 37uC
for 24 h.
Total iron-chelating activity and the amount of hydroxamate-
and catechol-type groups were measured in filter-sterilized culture
supernatants by the chrome azurol S (CAS) liquid assay [36], the
Csa `ky assay as modified by Gillam [37] and the Arnow test [38],
respectively.
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Hemolytic activity was assessed using both agar plate and liquid
assays. For plate assays, bacterial cells were grown in TSBD at
37uC for 14 h, normalized to an OD600 of 1 in sterile saline, and
5 ml aliquots were spotted on Columbia agar plates (Biokar
Diagnostics) supplemented with 5% sheep or horse defibrinated
blood (OXOID). Plates were incubated at 37uC for 48 h.
Hemolytic activity in culture supernatants was determined by
incubating filter-sterilized supernatants from bacterial cultures
grown in TSBD for 14 h in the presence of 10% (final
concentration) sheep or horse defibrinated blood, previously
washed several times with sterile ice-cold phosphate-buffered
saline (PBS), pH 7.4. After 3 h incubation at 37uC with gentle
agitation, intact erythrocytes were harvested by centrifugation at
1000 g and 4uC for 20 min. The amount of hemoglobin released
in supernatants was evaluated by measuring the OD545. The
percentage of hemolysis (P) was calculated using the equation
P=(X2B)/(T2B)6100, and then normalized to the cell density
(OD600) of the bacterial culture. X is the OD545 of the sample
analyzed, while B and T represent the baseline and total
hemolysis, i.e. the OD545 obtained with sterile TSBD and
deionized water instead of culture supernatant, respectively [39].
Phospholipase C activity assay
Extracellular phospholipase C activity was determined using the
chromogenic substrate p-nitrophenylphosphorylcholine (PNPC) as
described [40]. Briefly, 900 ml of a solution of 10 mM PNPC in
250 mM Tris-HCl, pH 7.2, 1 mM ZnCl2, 60% glycerol was added
to 100 ml of filter-sterilized supernatants from cultures grown for
14 h in TSBD. The reaction mixture was incubated at 37uC for
24 h and the OD405 was measured.
Proteolytic activity assay
Extracellular proteolytic activity was determined using the
azoalbumin assay as previously described [41]. Briefly, 500 mlo fa
1 mg/ml azoalbumin solution in Tris-HCl, pH 7.7, were added to
500 ml filter-sterilized supernatants from cultures grown in TSBD
for 14 h, and then incubated at 37uC for 24 h. Trichloroacetic
acid was added at 13% final concentration to precipitate the non-
degraded protein. Samples were incubated at 220uC for 20 min,
centrifuged at 15000 g for 10 min, and the OD440 of the resulting
supernatants was measured.
Biofilm assay
Biofilm formation was measured according to the microtiter
plate assay [42]. Bacterial cells were grown in TSBD for 14 h and
normalized to an OD600 of 1.0. Aliquots of 100 ml were transferred
to a sterile 96-well polystyrene microtiter plate (12 wells per strain)
and incubated at 37uC for 24 h. Planktonic cells were removed
and the attached cells were gently washed three times with sterile
PBS, air dried, and stained with 0.1% crystal violet solution for
15 min. After washing the wells four times with distilled water, the
surface-associated dye was solubilized by adding 200 ml of 95%
ethanol to each well. The dye solutions from three wells were
pooled and the OD540 was measured.
Surface motility assay
LB, CAA and TSBD plates containing 0.5% agarose were
prepared and strains were stab-inoculated with a pipette tip to the
bottom of the polystyrene Petri dish from bacterial colonies grown
overnight in LB agar (1.5%) plates. The plates were closed tightly
with parafilm to prevent drying and incubated at 37uC for 24 h.
Swarming motility was observed at the air-agarose interface.
Twitching motility was assessed by removing the agarose layer,
staining the plates with a 0.1% crystal violet solution for 30 min,
and measuring the diameter of the motility disk. A minimum of
three independent experiments was performed.
Assay for resistance to human serum
Resistance to human serum was measured according to the
protocol of Kim et al. [11]. In brief, bacterial cells grown in TSBD
for 14 h were washed and resuspended in PBS to an OD600 of 1.0.
Human serum from five healthy individuals was pooled together
and diluted in PBS to a 40% final dilution. Heat-inactivated serum
was prepared by incubating the same serum at 56uC for 30 min.
Bacterial suspensions were then added to human serum or heat-
inactivated serum to obtain a bacterial cell concentration of ca.
1610
7 CFU/ml and samples were incubated at 37uC for 2 h.
Viable counts were determined at 0 and 2 h time points, and three
independent experiments were performed.
Assay for resistance to desiccation
Resistance to desiccation was measured according to the
protocol of Jawad et al. [22]. Bacterial cells were grown in TSBD
for 14 h, washed twice with PBS and resuspended in distilled
water to an OD600 of 1. Twenty ml of each suspension (ca.
2610
7 CFU) were deposited onto sterile 13 mm diameter
rounded glass coverslips and placed in an uncovered petri dish
in an airtight transparent plastic box (17 by 11 by 5.5 cm). The
relative humidity inside the plastic boxes was maintained at 31%
by the presence of a saturated salt solution of CaCl2 in an open
5 ml beaker [22]. For viable cell determination, at each sampling
time point the glass coverslips were vortexed vigorously for 15 s in
2 ml of sterile distilled water, the cells were harvested by
centrifugation (2,0006g for 10 min), resuspended in 200 mlo f
saline solution and 100-ml aliquots of these suspensions (or of
appropriate dilutions) were plated onto LB agar plates by the
spread plate method. Three glass coverslips were analyzed for
each sample. In case of samples containing ,10 CFU/coverslip,
the absence of viable cells attached to the coverslip was confirmed
by placing the coverslip in 2 ml of LB medium. Bacterial growth
was never observed after 48 h at 37uC and 250 rpm.
Statistical analysis
Statistical analysis was performed with the software GraphPad
Instat, using One-Way Analysis of Variance (ANOVA) followed
by Tukey-Kramer multiple comparison tests. Survival plots were
generated by the Kaplan-Meier method and analyzed by the log-
rank test. Differences having a P value ,0.05 were considered to
be statistically significant.
Results
Virulence in the G. mellonella model of infection
G. mellonella has recently been proposed as a simple and useful in
vivo model to assess A. baumannii pathogenicity [20]. Accordingly,
the G. mellonella model of infection was used to compare the
virulence of A. baumannii strains AYE, ACICU, ATCC 17978 and
SDF. A representative time-kill experiment is illustrated in
Supporting Information (Fig. S1). The LD50 values were
calculated for each strain at 24, 48 and 72 h post-infection
(Table 1). For all strains, the LD50 values decreased with time of
incubation, attaining the final value at 48 h. No killing was
observed with heat-inactivated A. baumannii cells. No significant
differences in virulence were observed between the epidemic
strains AYE and ACICU and the non-epidemic strain ATCC
17978 (P.0.05), all three of which showed similar LD50 values
Acinetobacter baumannii Virulence Factors
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5 CFU). These results are comparable to those
obtained by Peleg et al. [20] for other clinical A. baumannii strains.
In contrast, the non-clinical strain SDF showed insufficient larval
killing to calculate the LD50, even at the highest inoculum size.
Thus, the estimated LD50 for SDF represents a theoretical
approximation to the actual LD50 value, and can confidently be
considered to be at least 100-fold higher than the LD50 values for
the three clinical strains.
Growth kinetics
In order to establish the optimal conditions for in vitro growth of
the different A. baumannii strains, the growth kinetics were
determined for each strain at temperatures ranging between 4
and 50uC in different minimal and complex growth media, namely
LB, M9 minimal medium, CAA and TSBD.
SDF grew slower than the other strains in all the media tested,
with TSBD being the only medium supporting the growth of SDF
to levels almost comparable to those of the other strains (Fig. 1;
data not shown). In general, TSBD and LB were found to be the
preferential media for growth of A. baumannii, with maximum
growth rates (mmax) of the clinical strains being slightly higher in
TSBD (average of 2.8 h
21 at 37uC) than in LB (average of 2.5 h
21
at 37uC). When grown at 37uC in TSBD, strains entered
stationary growth phase after ca. 10–12 h, with a doubling time
of ca. 40 min for clinical strains and 100 min for SDF.
All A. baumannii strains of clinical origin grew at temperatures
ranging between 25 and 45uC, with maximum growth rates at
37uC. In contrast, growth of the non-human SDF strain was
impaired at temperatures higher than 37uC (Fig. 1), a feature that
would hamper growth in humans during pyrexia.
Iron-uptake capability
The capability of the different A. baumannii strains to resist iron
starvation was compared by growing the strains on TSBD agar
plates in the presence of a gradient of the iron chelator 2,29-
dipyridyl (0–500 mM) (Fig. 2A). Considerable differences in
resistance to iron starvation were found between strains, with
clinical strains showing significantly higher capability to overcome
iron starvation than the non-human isolate SDF (Fig. 2A;
P,0.01).
In order to correlate the observed iron starvation resistance
profiles to the production of iron-chelating compounds, the
different A. baumannii strains were compared for total iron-
chelating activity released in culture supernatants, as well as for
production of iron-regulated molecules containing chemical
groups involved in iron chelation, namely hydroxamates and
catechols. To this aim, A. baumannii strains were grown in poor
(CAA) or rich (TSBD) medium supplemented with either 50 mM
2,29-dipyridyl or 50 mM FeCl3, as iron-depleted and iron-replete
growth conditions, respectively. While CAA is one of the reference
media used for iron-uptake studies, TSBD was chosen since it
supports growth of SDF to levels comparable to the other strains
(Fig. 1).
With the exception of SDF, all strains showed iron-chelating
activity in the supernatant of cultures grown under iron-depleted
growth conditions (Fig. 2B), consistent with the genomic
predictions. With regard to the chemical nature of the iron-
chelating groups, all the siderophore-producing strains secreted
comparable amounts of hydroxamate groups, while AYE showed
only marginal catechol production with respect to ACICU and
ATCC 17978 (Figs. 2C and D). Notably, the ratios between
hydroxamate and catechol groups released by strains ACICU and
ATCC 17978 were significantly different for the two growth media
(P,0.001). While both strains produced higher amounts of
Table 1. G. mellonella killing by A. baumannii strains.
Strain LD50 (± SEM)
a
24 h 48 h 72 h
AYE 7.51 (60.68)610
5 2.01 (60.05)610
5 1.98 (60.04)610
5
ACICU 6.64 (60.26)610
5 5.58 (60.09)610
5 5.54 (60.11)610
5
ATCC 17978 3.92 (60.10)610
5 2.42 (60.13)610
5 2.38 (60.12)610
5
SDF
bc 4.99 (60.31)610
7 4.84 (60.06)610
7 4.84 (60.06)610
7
aThe LD50 values are expressed in CFU and were calculated as described in
Materials and Methods after 24, 48 and 72 h of infection with A. baumannii
cells. Values are the mean (6 SEM) of at least three independent experiments
and were inferred from a regression curve calculated from at least six different
infecting inocula for each experiments.
bSince SDF causes insufficient killing of larvae for experimental determination of
the LD50 even at the highest infecting dose (i.e. 4610
7 CFU/larva), the reported
LD50 is a theoretical estimate generated by GraphPad Prism.
cThe difference between the LD50 values of SDF and those of clinical strains is
statistically significant (P,0.001) at every time point.
doi:10.1371/journal.pone.0022674.t001
Figure 1. A. baumannii growth kinetics. (A) Growth (OD600)o fA.
baumannii strains at 37uC in TSBD medium. (B) Temperature-dependent
growth kinetics, defined as maximum growth rates (mmax)o fA.
baumannii strains grown in TSBD medium at the different temperatures.
Values represent the mean (6 standard deviation, SD) of three
independent experiments. Symbols: AYE, squares; ACICU, circles; ATCC
17978, triangles; SDF, diamonds.
doi:10.1371/journal.pone.0022674.g001
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TSBD (Figs. 2C and D), indicating that the composition of the
growth medium may affect the production of the different iron-
chelating compounds.
Hemolytic activity
Although A. baumannii is generally considered to be a non-
hemolytic species [43], genomic analysis revealed the presence of
two phospholipase C genes and a number of hemolysin-related
genes in all the A. baumannii strains sequenced to date (Table S1
and ref. 19).
In order to assay the hemolytic activity, A. baumannii strains were
grown on 5% sheep or horse blood agar plates. Intriguingly, all
strains caused appreciable hemolysis of horse but not sheep
erythrocytes (Fig. 3A; data not shown). To quantify extracellular
hemolytic activity, filter-sterilized bacterial supernatants from
TSBD cultures were incubated with horse and sheep defibrinated
blood. Whereas no hemolysis was detected in the presence of
sheep blood, all strains caused hemolysis of horse erythrocytes to
levels comparable to that of P. aeruginosa PAO1, which was used as
a positive control (Fig. 3B).
Phospholipase C and exoprotease production
The genomes of the sequenced A. baumannii strains contain two
genes putatively coding for a phospholipase C and several genes
encoding putative secreted proteolytic enzymes (Table S1).
Therefore, phospholipase C and exoprotease activities were
compared in culture supernatants of the different A. baumannii
strains. All strains showed phospholipase C and protease activities
(Fig. 4). Whereas no statistically significant differences in
Figure 2. Iron-uptake capability. (A) Growth of A. baumannii strains on 2,29-dipyridyl gradient (0–500 mM) TSBD agar plates. The ordinate shows
the minimal inhibitory concentration of the iron chelator 2,29-dipyridyl. (B) Iron-chelating activity in culture supernatants of A. baumannii strains
grown in CAA supplemented with either 50 mM 2,29-dipyridyl or 50 mM FeCl3 (black and white bars, respectively) and TSBD supplemented with
50 mM 2,29-dipyridyl or 50 mM FeCl3 (light and dark gray bars, respectively). Values are expressed as percentage of siderophore units (U) normalized to
the cell density (OD600) of the bacterial culture. Amount of catechol (C) and hydroxamate (D) groups in the supernatants of A. baumannii cultures.
Values are expressed as concentration (mM) of hydroxamate or catechol groups normalized to the OD600 of the bacterial culture. Growth conditions
and symbols correspond to those described in the legend to panel B. Values represent the mean (6SD) of two independent experiments, each
including three biological replicates. ** P,0.01 (ANOVA).
doi:10.1371/journal.pone.0022674.g002
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ACICU and ATCC 17978 showed higher protease activities than
AYE and SDF (P,0.01; Fig. 4B).
Biofilm formation
Analysis of the A. baumannii genomes indicated that several genes
predicted to encode factors responsible for promoting and
regulating biofilm formation, e.g. pili and quorum sensing, were
differently distributed among A. baumannii strains [5,27,28].
Biofilm formation was compared among the different A. baumannii
strains by measuring cell adhesion to the surface of polystyrene
microtiter plate wells after static incubation at 37uC for 24 h.
Under these conditions, the non-clinical strain SDF showed $10-
fold higher ability to adhere to the surface and form biofilms with
respect to the clinical strains (P,0.001; Fig. 5). Among these, the
ACICU strain, representative of CC2, exhibited significantly
higher biofilm formation than the AYE strain, representative of
CC1, and the non-epidemic strain ATCC 17978 (P,0.05; Fig. 5),
in line with the recent observation that biofilm formation
capability is higher in isolates belonging to CC2 compared with
CC1 isolates [44].
Surface motility
The A. baumannii genomes contain several genes and gene
clusters putatively responsible for type IV pilus-mediated twitching
motility. Compared with the epidemic strains AYE and ACICU,
strain ATCC 17978 lacks three genes predicted to be involved in
pilus adhesion, whilst SDF lacks most genes essential for pilus
biogenesis and functioning (Table S2).
Surface motility was assessed on LB, CAA and TSBD plates
containing 0.5% agarose. After incubation at 37uC for 24 h,
twitching motility was measured in terms of the bacterial spread at
the agarose/petri plate interface [45]. Twitching was observed for
AYE in LB and TSBD, but not in CAA plates, while the other
strains did not twitch in any of the tested media (Fig. 6 and data
not shown). Moreover, different forms of swarming were detected
at the air/agarose interface for ATCC 17978 in CAA and for AYE
in TSBD medium (Fig. S2).
Resistance to human serum and desiccation
The different A. baumannii strains were compared for the ability
to survive for long periods on dry surfaces and the ability to avoid
the bactericidal activity of human serum. Overall, ACICU, AYE
and SDF displayed a comparable resistance to human serum,
while ATCC 17978 showed lower survival in the presence of
human serum, a difference which was statistically significant only
with respect to ACICU (P,0.01; Fig. 7A). On the other hand, the
A. baumannii strains showed a considerably different ability to
survive on dry surfaces (Fig. 7B). The louse strain SDF was
strongly impaired in its ability to resist desiccation (survival time
less than 10 days). The non-epidemic strain ATCC 17978 and the
representative CC2 strain ACICU showed comparable trends of
survival (survival time of 40–70 days). Notably, the representative
CC1 strain AYE showed extremely high resistance to desiccation,
surviving on dry surfaces for more than 100 days (Fig. 7B).
Discussion
A. baumannii is an emerging human pathogen responsible for a
broad array of nosocomial infections. Its ability to persist in the
hospital setting and to steadfastly acquire antibiotic resistance has
become a global concern for the medical community [1,3]. Most
studies have focused on the epidemiology and evolution of
antibiotic resistance of A. baumannii; however, the basis of its
virulence remains ill-defined.
Recently, Peleg and coworkers demonstrated the suitability of
G. mellonella as a model to study A. baumannii-host interactions [20].
This simple animal model of infection was used in the present
study to compare the pathogenicity of four A. baumannii strains with
completely sequenced genomes. Three of these strains were
isolated from clinical specimens of infected patients, including two
MDR representatives of CC1 and CC2 and the sporadic isolate
ATCC 17978. The fourth strain, SDF, has a non-human origin,
although it has been suggested that its isolation from a body louse
could result from the ingestion of contaminated blood from a
bacteremic patient. While no significant differences in virulence
were observed among the clinical strains, irrespective of their
resistance phenotype or their classification as epidemic (AYE and
ACICU) or sporadic (ATCC 17978), the body louse strain SDF
was practically avirulent in this model of infection, suggesting that
this strain could be used as a pathogenicity-defective benchmark in
the search for novel A. baumannii virulence determinants.
Figure 3. Hemolytic activity. (A) Hemolysis on 5% horse blood
Columbia agar plates. A. baumannii strains are, from top left in
clockwise order: AYE, ACICU, ATCC 17978 and SDF. P. aeruginosa PAO1
was spotted on the center of the plate as positive control for hemolysis.
Hemolysis is evidenced by the transparent halo around the colony. (B)
Hemolytic activity on horse and sheep erythrocytes (black and white
bars, respectively) of cell-free supernatants from A. baumannii cultures
grown in TSBD medium. Hemolytic activity was normalized to the
OD600 of the bacterial culture. Values represent the mean (6 SD) of two
independent experiments, each including three biological replicates.
doi:10.1371/journal.pone.0022674.g003
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lack of specific virulence trait(s), the presence and expression of
several virulence factors, namely hemolysins, phospholipase C,
exoproteases and iron acquisition systems, were investigated by a
combined approach of genomic and phenotypic analysis. In
addition, several multifactorial phenotypes, such as growth
capability, motility, biofilm formation and resistance to serum,
iron deficiency and desiccation, were analyzed, as all these
phenotypes are known to contribute to the pathogenicity and
ecological fitness of other opportunistic bacterial pathogens.
On the whole, the A. baumannii clinical isolates displayed the
ability to express a number of virulence determinants, including
exoproducts with hemolytic, phospholipase and protease activities,
and siderophore-based iron uptake mechanisms. This is in full
agreement with the presence in their genomes of specific genes for
the synthesis of such potential virulence factors [25,27,28,29].
Notably, the hemolytic activity of A. baumannii strains is much
more evident in liquid assay than on agar plates, and can be
detected using horse, but not sheep, erythrocytes (Fig. 3). This
intriguing result could explain why A. baumannii has historically
been regarded as a non-hemolytic bacterium [43].
Differences were observed in the production of specific
virulence factors between the non-human isolate SDF and the
clinical strains, with the most noteworthy being the inability of
SDF to use siderophores as an iron-uptake strategy, which affects
its ability to grow under iron-depleted conditions (Fig. 2). On the
Figure 4. Production of virulence-related exoproteins. Phospholipase C (A) and total proteolytic (B) activities in filter-sterilized supernatants of
the different A. baumannii strains grown for 14 h in TSBD at 37uC. Activities are expressed in U/L of culture supernatants and normalized to the OD600
of the bacterial cultures. P. aeruginosa PAO1 was used as positive control for phospholipase C and proteolytic activities. Values represent the mean (6
SD) of three independent experiments. ** P,0.01 (ANOVA).
doi:10.1371/journal.pone.0022674.g004
Figure 5. Biofilm formation. Biofilm formation on 96-well polysty-
rene microtiter plates by A. baumannii strains grown statically in LB
medium for 24 h. Values represent the mean (6 SD) of five
independent experiments performed in quadruplicate. * P,0.05, ***
P,0.001 (ANOVA).
doi:10.1371/journal.pone.0022674.g005
Figure 6. Twitching motility. A. baumannii twitching motility after
24 h of growth at 37uC in TSBD medium. A. baumannii strains are, from
top-left in clockwise order: AYE, ACICU, SDF and ATCC 17978. The plate
shown in the figure is representative of three independent experiments
giving similar results.
doi:10.1371/journal.pone.0022674.g006
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activities comparable to the average values obtained for the
clinical strains (Figs. 3 and 4), suggesting that the reduced
virulence of SDF in the G. mellonella model of infection cannot be
ascribed to any of these factors. It should be pointed out that SDF
showed limited metabolic capabilities, as inferred by its lower
growth kinetics and biomass yields in the majority of culture media
tested, as compared to the clinical A. baumannii strains (Fig. 1; data
not shown). The genome of SDF is much smaller than that of the
other A. baumannii genomes sequenced to date [5], presumably as a
result of extensive insertion sequence-mediated deletion events
[27]. Given that strain SDF was isolated from a human body
louse, its adaptation to such a restricted host might provide an
explanation for the reductive evolution of its genome and,
consequently, for its metabolic restrictions, as documented for
other pathogens restricted to a narrow ecological niche [reviewed
in ref. 46]. Therefore, the virulence defect of SDF in G. mellonella
can more likely be ascribed to a reduced ability to grow and persist
in this model host than to impaired production of any virulence
factor among those analyzed in the present study.
Someinteresting differences wereobserved among the strains with
respect to the multifactorial phenotypes related to pathogenesis, such
as biofilmformation, motility and resistance to desiccation. The non-
human isolate SDF was strongly impaired in its ability to survive on
drysurfacescompared totheclinicalisolates(Fig.7B),suggestingthat
the ability to persist under dry conditions may represent a factor
accounting for A. baumannii survival in the hospital setting and,
ultimately, for its ability to cause outbreaks of infection.
A remarkable differencewasobserved between the representative
CC1 and CC2 strains with regard to surface motility. While AYE
displayed both twitching and swarming motilities, ACICU was
apparently non-motile (Fig. 6), despite carrying the genetic potential
to encode functional type IV pili (Table S2). Additional studies are
required to assess whether the lack of motility is a specific feature of
strain ACICU or a common trait of CC2 members.
Finally, it is worth noting that strain SDF is endowed with a
surprisingly high capability to adhere to abiotic surfaces and to form
biofilm. Very recently, de Breij and coworkers showed that no
evident correlation exists in A. baumannii strains between biofilm
formation capability and clinical impact [44]. The results obtained
with SDF are in agreement with this conclusion. Intriguingly, the
genome of SDF lacks most of the factors which have been
implicated in A. baumannii biofilm formation, namely Csu pili, the
quorum sensing signal synthaseAbaIand exopolysaccharidePNAG
synthesis enzymes (http://www.genome.jp/kegg/), suggesting ei-
ther that these systems are not essential for biofilm development or
that strain SDF possesses alternative compensatory function(s).
However, a search for gene clusters exclusive to the genome of SDF
did not reveal any obvious candidate(s), but a number of genomic
regions of prophage origin with unpredictable function were
identified. Whether these regions provide SDF with additional
functions related to biofilm formation remains to be assessed.
In summary, the present work confirms the multifactorial nature
of A. baumannii virulence, with no unique virulence factor being
identified that individually accounts for the pathogenic success of
this bacterium. Moreover, the results indicate that metabolic
capabilities and resistance to environmental stresses might be more
important for A. baumannii pathogenicity than the production of
specific virulence factors. In support of this, it is noteworthy that
genes coding for the only factors demonstrated to affect A.
baumannii pathogenicity in vivo (OmpA, phospholipase D and
penicillin-binding protein 7/8) are present in all annotated A.
baumannii genomes, including the avirulent strain SDF, as well as in
the genome of the related soil bacterium Acinetobacter baylyi (http://
www.genome.jp/kegg/). The present investigation strengthens the
view that the epidemic potential of A. baumannii is more likely
related to the MDR phenotype than to the production of specific
virulence factor(s) [1,5], as shown here by the overall similarity of
the virulence-related phenotype between epidemic MDR strains
AYE and ACICU and the sporadic isolate ATCC 17978.
A comparative-genomics analysis recently demonstrated that the
SDF genome is highly divergent from the genomes of clinical A.
baumannii s t r a i n s[ 5 ] .T h i sw o r ks h o w st h a ts u c hd i v e r s i t yr e f l e c t su p o n
the atypical phenotype of SDF with regard to growth rate, iron
uptake, biofilm formation and resistance to stress, compared with the
clinical strains. Furthermore, the attenuated virulence in the insect
model of infection argues against any potential role of SDF as a
human pathogen. Further studies are mandatory to understand the
actual distribution of such aberrant A. baumannii strains in reservoirs
other than the hospital setting, which could possibly help to
reconstruct the evolution of A. baumannii toward human pathogenicity.
Supporting Information
Table S1 A. baumannii genomic ORFs predicted to encode
hemolysin-, phospholipase- and exoprotease-related proteins.
(DOC)
Figure 7. Resistance to human serum and desiccation. (A) Serum
resistance of A. baumannii strains. Resistance was determined as the
percentage of survival in 40% non-heated serum relative to survival in
heated serum. Values represent the mean (6 SD) of five independent
experiments. (B) Resistance to desiccation of A. baumannii strains: AYE
(squares), ACICU (circles), ATCC 17978 (triangles) and SDF (diamonds).
Strains were inoculated onto 13-mm diameter rounded glass coverslips
and incubated at 22uC and 31% relative humidity. A starting bacterial
inoculum of 2610
7 CFU per coverslip was used. Values represent the
mean (6 SD) of three independent experiments. The lower detection
limit of the assay is 10 CFU per coverslip. ** P,0.01 (ANOVA).
doi:10.1371/journal.pone.0022674.g007
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proteins related to type IV pilus biogenesis and functioning.
(DOC)
Figure S1 Kaplan-Meier survival plots of G. mellonella larvae
infected with the different A. baumannii strains. Time-kill results
from a representative experiment are shown, which were obtained
by inoculating 10
4 (A), 10
5 (B), 10
6 (C) or 10
7 (D) bacterial cells per
larva. Strains are: AYE (dashed red lines), ACICU (straight green
lines), ATCC 17978 (dashed blue lines) and SDF (straight black
lines). Statistically significant differences (P,0.05 calculated by the
log-rank test option of GraphPad) were only observed between
SDF and the three clinical strains, but not between clinical strains.
(PPT)
Figure S2 Swarming-like motility on the air-agarose interface of
ATCC 17978 on TSBD plates (A) and AYE on CAA plates (B)
after 24 h of growth at 37uC. The plates are representative of three
independent experiments giving similar results.
(PPT)
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